CFDE Data Portal | Search LOC101928988

	Label	Description
	LOC101928988 associations Collection (Entity type)	Associations for LOC101928988_associations
	LOC101928988 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	LOC101928988 Gene (Entity type)	ENSG00000259351 - uncharacterized LOC101928988
	GSE239844 crizotinib 8 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 6 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 4 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE145285 PRMT5 p53 inhibition RNA Messenger 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE229973 cisplatin 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 2 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Muscle 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx

LOC101928988 associations

Associations for LOC101928988_associations

LOC101928988 associations.tsv

A file from IDG as part of the Harmonizome project

LOC101928988

ENSG00000259351 - uncharacterized LOC101928988

GSE239844 crizotinib 8 v 10 human up

A Gene Set from LINCS

GSE239844 crizotinib 6 v 10 human up

A Gene Set from LINCS

GSE239844 crizotinib 4 v 10 human up

A Gene Set from LINCS

GSE145285 PRMT5 p53 inhibition RNA Messenger 0 v 1 human up

A Gene Set from LINCS

GSE229973 cisplatin 4 v 2 human up

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 2 v 6 human dn

A Gene Set from LINCS

GTEx Muscle 20-29 vs 60-69 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.